Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds antigen or epitope whose amino acid sequence is...
Reexamination Certificate
2011-04-05
2011-04-05
Saoud, Christine J (Department: 1647)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Binds antigen or epitope whose amino acid sequence is...
C530S387900
Reexamination Certificate
active
07919091
ABSTRACT:
The present invention relates to antibodies specific for a receptor termed the Lipolysis Stimulated Receptor (LSR). Compositions comprising the antibodies are also provided.
REFERENCES:
patent: 5194596 (1993-03-01), Tischer et al.
patent: 5270170 (1993-12-01), Schatz et al.
patent: 5350836 (1994-09-01), Kopchik et al.
patent: 5635373 (1997-06-01), Wozney et al.
patent: 6126939 (2000-10-01), Eisenbach-Schwartz et al.
patent: 6344441 (2002-02-01), Bihain et al.
patent: 6579852 (2003-06-01), Fruebis et al.
patent: 7220722 (2007-05-01), Bihain et al.
patent: 2002/0165154 (2002-11-01), Bihain et al.
patent: 2003/0100500 (2003-05-01), Fruebis et al.
patent: 2004/0067881 (2004-04-01), Fruebis et al.
patent: WO 96/30400 (1996-10-01), None
patent: WO 96/34981 (1996-11-01), None
patent: WO 96/39429 (1996-12-01), None
patent: WO 97/27286 (1997-07-01), None
patent: WO 98/01257 (1998-01-01), None
patent: WO 98/20165 (1998-05-01), None
Alexeev and Yoon “Stable and inheritable changes in genotype and phenotype of albino melanocytes induced by an RNA-DNA oligonucleotide,”Nature Biotech. (1998), vol. 16, pp. 1343-1346.
Austin, et al. “Hypertriglyceridemia as a Cardiovascular Risk Factor,”Am. J. Cardiol. (1998), vol. 81, pp. 7B-12B.
Baldo, et al. “The Adipsin-Acylation Stimulating Protein System and Regulation of Intracellular Triglyceride Synthesis,”J. Clin. Invest. (1993), vol. 92, pp. 1543-1547.
Bartles, J.R., et al. “Biogenesis of the Rate Hepatocyte Plasma Membrane,”Methods Enzymol. (1990), vol. 191, pp. 825-841.
Bihain, et al. “Free Fatty Acids Activate a High Affinity Saturable Pathway for Degradation of Low-Density Lipoproteins in Fibroblasts from a Subject Homozygous for Familial Hypercholesterolemia,”Biochemistry(1992), vol. 31, No. 19, pp. 4628-4636.
Brendel, V. et al. “Methods and algorithms for statistical analysis of protein sequences,”Proc. Natl. Acad. Sci. USA(1992), vol. 89, pp. 2002-2006.
Chen, W.J. et al. “NPXY, a sequence often found in cytoplasmic tails, is required for coated pit-mediated internalization of the low density lipoprotein receptor,”J. Biol. Chem. (1990), vol. 265, pp. 3116-3123.
Cole-Strauss et al. “Correction of the Mutation Responsible for Sickle Cell Anemia by an RNA-DNA Oligonucleotide,”Science(1996), vol. 273, pp. 1386-1389.
Davis, C.G. et al. “The J.D. Mutation in Familial Hypercholesterolemia: Amino Acid Substitution in Cytoplasmic Domain Impedes Internalization of LDL Receptors,”Cell(1986), vol. 45, pp. 15-24.
Dietrich, J. et al. “CD3γ Contains a Phosphoserine-Dependent Di-Leucine Motif Involved in Down-Regulation of the T Cell Receptor,”EMBO Journal(1994), vol. 13, pp. 2156-2166.
Everhart, J.E. “Weight Change and Obesity After Liver Transplantation: Incidence and Risk Factors,”Liver Transpl. Surg. (1998), vol. 4, pp. 285-296.
Feeman, Jr., W.E. “Hypertriglyceridemia and Atherosclerosis,”Annals of Internal Med. (1998), vol. 128, No. 1, pp. 73-74.
Ghebrehiwet, et al. “Isolation, cDNA Cloning, and Overexpression of a 33-kD Cell Surface Glycoprotein that Binds to the Globular “Heads” of C1q,”J. Exp. Med. (1994), vol. 179, No. 6, pp. 1809-1821.
Goldstein, J.L., et al. “Familial Hypercholesterolemia,” inThe Metabolic and Molecular Bases of Inherited Disease(vol. II, 7thed., Scriver, C.R., Beaudet, A.L., Sly, W.S., Valle, B. editors, 1995), pp. 1981-2030; McGraw-Hill; New York, New York, USA.
Goldstein, et al. “Hyperlipidemia in Coronary Heart Disease,”J. Clin. Invest. (1973), vol. 52, pp. 1533-1543.
Gura, et al. “Obesity Sheds Its Secrets,”Science(1997), vol. 275, pp. 751-753.
Hayward, et al. “The cDNA Sequence of Human Endothelial Cell Multimerin,”J. Biol. Chem. (1995), vol. 270, pp. 18246-18251.
Henrion, et al. “Structure, Sequence and Chromosomal Location of the Gene for USF2 Transcription Factors in Mouse,”Genomics(1995), vol. 25, pp. 36-43.
Herz, J., et al. “Surface Location and High Affinity for Calcium of a 500-kd liver Membrane Protein Closely Related to the LDL-receptor Suggest a Physiological Role as Lipoprotein Receptor,”European Molecular Biology Laboratory(1988), vol. 7, pp. 4119-4127.
Honore, B., et al. “Cloning and Expression of a cDNA Covering the Complete Coding Region of the P32 subunit of Human pre-mRNA Splicing Factor SF2,”Gene(1993), vol. 134, pp. 283-287.
Hu, E., et al. “AdipoQ is a Novel Adipose-specific Gene Dysregulated in Obesity,”J. Biol. Chem. (1996), vol. 271, No. 18, pp. 10697-10703.
Huettinger, M., et al. “Charecteristics of Chlylomicron Remnant Uptake into Rat Liver,”Clin. Biochem. (1988), vol. 21, pp. 87-92.
Karpe, F., et al. “Clearance of Lipoprotein Remnant Particles in Adipose Tissue and Muscle in Humans,”J. Lipid, Res. (1997), vol. 38, pp. 2335-2343.
Karpe, F., et al. “Magnitude of Alimentary Lipemia is Related to Intima-media Thickness of the Common Carotid Artery in Middle-aged Men,”Elsevier Science Ireland(1998), vol. 141, pp. 307-314.
Krainer, A.R., et al. “Functional Expression of Cloned Human Splicing Factor SF2: Homology to RNA-Binding Proteins, U1 70K, andDrosophilaSplicing Regulators,”Cell(1991), vol. 66, pp. 383-394.
Lee, M. G-S., et al. “Charecterization of a cDNA Encoding a Cysteine-Rich Cell Surface Protein Located in the Flagellar Pocket of the ProtozoanTrypanosoma brucei,” Molec. Cell. Biol. (1990), vol. 10, pp. 4506-4517.
Letourneur, F., et al. “A Novel Di-Leucine Motif and a Tyrosine-Based Motif Independently Mediate Lysosomal Targeting and Endocytosis of CD3 Chains,”Cell(1992), vol. 69, pp. 1143-1157.
Lewis, G.F., et al. “Postprandial Lipoprotein Metabolism in Normal and Obese Subjects: Comparison after the Vitamin A Fat-Loading Test,”J. of Clinic. Endo. (1990), vol. 71, pp. 1041-1050.
Lin, et al. “Archaic Structure of the Gene Encoding Transcription Factor USF,”Journal of Biological Chemistry(1994), vol. 269, No. 19, pp. 23894-28903.
Liu, Q., et al. “Design of Polydactyl Zinc-finger Proteins for Unique Addressing within Complex Genomes,”Proc. Natl. Acad. Sci. USA(1997), vol. 94, pp. 5525-5530.
Maeda, et al. “cDNA Cloning and Expression of a Novel Adipose Specific Collagen-like Factor, apM1 (AdiposeMost Abundant Gene Transcript 1),”Biochem. And Biophys. Research Comm. (1996), vol. 221, pp. 286-289.
Mahley, R.W., et al. “Type III Hyperlipoproteinemia (Dysbetalipoproteinemia): The Role of Apolipoprotein E in Normal and Abnormal Lipoprotein Metabolism,” inThe Molecular Basis of Inherited Disease(1995), pp. 1953-1980; Scriver CR, Beaudet, A.L., Sly, W.S., Valle, D., editors; McGraw-Hill; New York.
Mann, et al. “Mechanism of Activation and Functional Significance of the Lipolysis-Stimulated Receptor. Evidence for Role as Chylomiscron Remnant Receptor,”Biochemistry(1995), vol. 34, No. 33, pp. 10421-10431.
Massie, et al. “Inducible Overexpression of a Toxic Protein by an Andenovirus Vector with a Tetracycline-Regulatable Expression Cassette,”Journal of Virology(1998), vol. 72, pp. 2289-2296.
Montague, et al. “Congenial Leptin Deficiency is Associated with Severe Early-onset Obesity in Humans,”Nature(1997), vol. 387, pp. 903-908.
Parra-Lopez, C.A., et al., “Presentation on Class II MHC Molecules of Endogenous Lysozyme Targeted to the Endocytic Pathway,”J. Immunol. (1997), vol. 158, pp. 2670-2679.
Pengue, G., et al. “Repression of Transcriptional Activity at a Distance by the Evolutionary Conserved KRAB Domain Present in a Subfamily of Zinc Finger Proteins,”Nucleic Acids Research(1994), vol. 22, No. 15, pp. 2908-2914.
Rajput-Williams,J., et al. “Variation of Apolipoprotein-B Gene is Associated with Obesity, High Blood Cholesterol Levels, and Increased Risk of Coronary Heart Dis
Bihain Bernard
Bougueleret Lydie
Yen-Potin Frances
Institut National de la Sante Et de la Recherche Medicale (Inser
Saliwanchik Lloyd & Eisenschenk
Saoud Christine J
Serono Genetics Institute S.A.
LandOfFree
Lipolysis stimulated receptor (LSR) specific antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lipolysis stimulated receptor (LSR) specific antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lipolysis stimulated receptor (LSR) specific antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2725699